Bottom line
LHCOX vs QAAGZX: the short answer
LHCOX (Lord Abbett Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 47% by weight.
But QAAGZX is far broader, holding 277 positions to 61 for LHCOX, so beyond the top names it adds exposure LHCOX doesn't have.
LHCOX is cheaper at 0.68% vs 0.86% — a difference of $18 a year per $10,000 invested.
Over five years, LHCOX returned +4.8% a year vs +4.1% for QAAGZX.
Updated Nov 19, 2026
LHCOX vs QAAGZX side by side
| LHCOX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Lord Abbett | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.68% | 0.86% |
| Annual cost per $10k | $68 | $86 |
| 10-yr cost on $10k (prospectus) | $3,267 | $1,061 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +18.1% | +18.1% |
| 5-yr return (annualized) | +4.8% | +4.1% |
| 10-yr return (annualized) | — | +9.0% |
| Best quarter | — | +23.4% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $8.6M | $751.7M |
| Number of holdings | 61 | 277 |
| Portfolio turnover | 91% | 65% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of LHCOX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | LHCOX | QAAGZX |
|---|---|---|
| Eli Lilly & Co | 10.40% | 14.06% |
| UnitedHealth Group Inc | 5.39% | 5.88% |
| Johnson & Johnson | 4.96% | 6.64% |
| Natera Inc | 3.60% | 1.44% |
| Gilead Sciences Inc | 3.53% | 2.79% |
| CVS Health Corp | 3.33% | 0.93% |
| Guardant Health Inc | 2.61% | 1.22% |
| Thermo Fisher Scientific Inc | 2.31% | 2.53% |
| Vertex Pharmaceuticals Inc | 2.24% | 2.26% |
| Protagonist Therapeutics Inc | 1.44% | 0.85% |
Source: SEC Form N-PORT
LHCOX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between LHCOX and QAAGZX?
Which is cheaper, LHCOX or QAAGZX?
Should I own both LHCOX and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.